Evaluation of the relationship between hepatocellular carcinoma location and transarterial chemoembolization efficacy

Table 1 Baseline characteristics (n = 115 patients, 127 nodules) n (%)

Characteristics	Values
Age
Median (range)	73 (49-92)
Sex
Male/Female	88 (76.5)/27 (23.5)
Etiology
Hepatitis B/C/B + C	13 (11.3)/85 (73.9)/2 (1.7)
Alcohol	10 (8.7)
NASH	2 (1.7)
PBC	3 (2.6)
Child-Pugh class
A/B	99 (86.1)/16 (13.9)
Location of target nodules
Anterior segment	39 (30.7)
Posterior segment	37 (29.1)
Medial segment	27 (21.3)
Lateral segment	24 (18.9)
Size of target nodules (mm)1	14.00 ± 10.30 (5.0-56.7)
Chemotherapeutic drug
Cisplatin/Epirubicin	87 (68.5)/40 (31.5)

¹Values are continuous data and are presented as the means ± SD. Numbers in parentheses are the ranges. NASH: Non-alcoholic stea-tohepatitis; PBC: Primary biliary cirrhosis.